Robert D. Toto

1990–2025 年に発表

別表記
Robert D Toto
124
論文数
28,596
被引用数
79
h 指数
122
i10 指数

被引用数

Robert D. Toto の年別被引用数1992 年: 被引用 1 件1993 年: 被引用 4 件1994 年: 被引用 1 件1995 年: 被引用 5 件1996 年: 被引用 6 件1997 年: 被引用 14 件1998 年: 被引用 21 件1999 年: 被引用 18 件2000 年: 被引用 15 件2001 年: 被引用 23 件2002 年: 被引用 56 件2003 年: 被引用 74 件2004 年: 被引用 115 件2005 年: 被引用 117 件2006 年: 被引用 122 件2007 年: 被引用 131 件2008 年: 被引用 97 件2009 年: 被引用 140 件2010 年: 被引用 154 件2011 年: 被引用 177 件2012 年: 被引用 206 件2013 年: 被引用 234 件2014 年: 被引用 228 件2015 年: 被引用 199 件2016 年: 被引用 153 件2017 年: 被引用 180 件2018 年: 被引用 160 件2019 年: 被引用 667 件2020 年: 被引用 710 件2021 年: 被引用 729 件2022 年: 被引用 733 件2023 年: 被引用 675 件2024 年: 被引用 1,041 件2025 年: 被引用 556 件2026 年: 被引用 24 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,855 件、この内訳の 24.3%イギリス: 引用元論文 835 件、この内訳の 7.1%中国: 引用元論文 796 件、この内訳の 6.8%ドイツ: 引用元論文 660 件、この内訳の 5.6%イタリア: 引用元論文 577 件、この内訳の 4.9%オーストラリア: 引用元論文 528 件、この内訳の 4.5%日本: 引用元論文 514 件、この内訳の 4.4%カナダ: 引用元論文 487 件、この内訳の 4.2%オランダ: 引用元論文 467 件、この内訳の 4%スペイン: 引用元論文 333 件、この内訳の 2.9%フランス: 引用元論文 309 件、この内訳の 2.6%スウェーデン: 引用元論文 237 件、この内訳の 2%
0%24.3%その他 26.7%

分野

  • Medicine81.5%
  • Biochemistry, Genetics and Molecular Biology11.8%
  • Health Professions1.2%
  • Nursing1.1%
  • Immunology and Microbiology0.8%
  • Neuroscience0.8%
  • その他2.8%

トピック

  • Chronic Kidney Disease and Diabetes8.6%
  • Dialysis and Renal Disease Management7.5%
  • Diabetes Treatment and Management6.8%
  • Blood Pressure and Hypertension Studies5.6%
  • Erythropoietin and Anemia Treatment2.5%
  • Hormonal Regulation and Hypertension2.4%
  • その他66.6%

共著者

全論文

検索で開く
  1. An atlas of healthy and injured cell states and niches in the human kidney

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sylvia E. Rosas, F. Perry Wilson, Paul M. Palevsky, Krzysztof Kiryluk, John R. Sedor, Robert D. Toto, Chirag R. Parikh, Eric H. Kim, Rahul Satija, Anna Greka, Evan Z. Macosko, Peter V. Kharchenko, Joseph P. Gaut, Jeffrey B. Hodgin, Richard A. Knight, Stewart H. Lecker, Isaac E. Stillman, Afolarin Amodu, Titlayo Ilori, Shana Maikhor, Insa M. Schmidt, Gearoid M. McMahon, Astrid Weins, Nir Hacohen, Lakeshia Bush, Agustin Gonzalez‐Vicente, Jonathan J. Taliercio, John O’Toole, Emilio D. Poggio, Leslie Cooperman, Stacey E. Jolly, Leal Herlitz, Jane Nguyen, Ellen L. Palmer, Dianna Sendrey, Kassandra Spates-Harden, Paul S. Appelbaum, Jonathan Barasch, Andrew S. Bomback, Vivette D. D’Agati, Karla Mehl, Pietro A. Canetta, Ning Shang, Olivia Balderes, Satoru Kudose, Laura Barisoni, Theodore Alexandrov, Ying‐Hua Cheng, Kenneth W. Dunn, Katherine J. Kelly, Timothy A. Sutton, Yumeng Wen, Celia P. Corona-Villalobos, Steven Menez, Avi Z. Rosenberg, Mohammed Atta, Camille Johansen, Jennifer K. Sun, Neil Roy, Mark Williams, Evren U. Azeloglu, Cijang He, Ravi Iyengar, Jens Hansen, Yuguang Xiong, Brad H. Rovin, Samir V. Parikh, Sethu M. Madhavan, Christopher Anderton, Ljiljana Paša‐Tolić ほか 70 名 - Nature 2023 被引用: 693

  2. Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial

    著者: , , , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2020 被引用: 530

  3. Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease

    著者: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2013 被引用: 994

  4. Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk

    著者: , , , , , , , , , , , , , , , , , , , - JAMA 2018 被引用: 1,087

  5. A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy

    著者: , , , , , , , , , , , , , , - Kidney International 2021 被引用: 397

  6. Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eduardo Verde, Eduardo Gutiérrez, Enyu Imai, Fan Fan Hou, Fernando Caravaca, Fernando C. Fervenza, Francesco Locatelli, Francesco Paolo Schena, Fumiaki Kobayashi, Gabriella Moroni, Gavin J. Becker, Gerald J. Beck, Gerald B. Appel, Gershon Frisch, GG van Essen, Giuseppe Maschio, Giuseppe Remuzzi, Giuseppe Montogrino, Hans‐Henrik Parving, Hiddo J.L. Heerspink, Hirofumi Makino, Imitiaz Jehan, Jack F.M. Wetzels, James V. Donadío, Jamie P. Dwyer, Jan A.J.G. van den Brand, John W. Kusek, John M. Lachin, José Luño, Julia B. Lewis, Jürgen Floege, Kaleab Z. Abebe, K.-M. Chow, Lawrence G. Hunsicker, Lucia Del Vecchio, Manno Carlo, Manuel Praga, Marián Goicoechea, Maximilian von Eynatten, Neil Poulter, Nish Chaturvedi, Patrizia Passerini, Paul E. de Jong, Peter J. Blankestijn, Philip H. Li, Piero Ruggenenti, P Zucchelli, Priscilla Kincaid‐Smith, R.-D Hilgers, Raymond O. Estacio, Richard D. Rohde, Ritsuko Katafuchi, Robert D. Toto, Robert W. Schrier, Roger A. Rodby, Ronald D. Perrone, Sadayoshi Ito, Saulo Klahr, Simeone Andrulli, Svend Strandgaard, Tak Mao Chan, Thierry Hannedouche, Thomas Rauen, Tom Greene, Úrsula Verdalles, Vlado Perkovic, William F. Keane - The Lancet Diabetes & Endocrinology 2019 被引用: 372

  7. A meta-analysis of GFR slope as a surrogate endpoint for kidney failure

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Brendan J. Barrett, Bruce Neal, Vlado Perkovic, Kenneth W. Mahaffey, David W. Johnson, Meg Jardine, Maximilian von Eynatten, Eduardo Verde, Úrsula Verdalles, David Arroyo, Arlene B. Chapman, Vicente E. Torres, Alan S.L. Yu, Godela Brosnahan, Thierry Hannedouche, Kai‐Ming Chow, Cheuk‐Chun Szeto, Chi‐Bon Leung, Di Xie, Fan Fan Hou, Jamie P. Dwyer, Marc A. Pohl, Itamar Raz, Lawrence G. Hunsicker, An Vanacker, Thomas Malfait, Giuseppe Maschio, Francesco Locatelli, Peter J. Blankestijn, Arjan van Zuilen, Fumiaki Kobayashi, Hirofumi Makino, Juliana C.N. Chan, Simeone Andrulli, Claudio Pozzi, Donatella Casartelli, Manuel Praga, Hernando Trujillo, Teresa Cavero, Ángel Sevillano, Piero Ruggenenti, Annalisa Perna, Fabiola Carrara, William F. Keane, Carlo Manno, Richard Haynes, William G. Herrington, Colin Baigent, Martin Landray, Thomas Rauen, Claudia Seikrit, Stefanie Wied, Robert D. Toto, Paul E. de Jong, Mauro Saddelli - Nature Medicine 2023 被引用: 157

  8. Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes

    著者: , , , , , , , , , , , - New England Journal of Medicine 2011 被引用: 876

  9. Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial

    著者: , , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2021 被引用: 208

  10. A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

    著者: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2009 被引用: 2,076

  11. Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease

    著者: , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2021 被引用: 196

  12. Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial

    著者: , , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2021 被引用: 194

  13. Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Roland E. Schmieder, Christoph Wanner, Pantelis Sarafidis, Juliana C.N. Chan, László Rosivall, Joseph A. Eustace, Ehud Grossman, Yoram Yagil, Giuseppe Remuzzi, Daisuke Koya, Takashi Wada, Magdalena Madero Rovalo, Ron T. Gansevoort, Adriaan Kooy, Trine Finnes, Froilan DeLeon, Janusz Gumprecht, Fernando Teixeira e Costa, Alexander Dreval, Anantharaman Vathsala, Aslam Amod, Sin Gon Kim, Byung‐Wan Lee, Julio Pascual Santos, Bengt-Olov Tengmark, Michel Burnier, Chien‐Te Lee, Sukit Yamwong, Ramazan Sarı, Kieran McCafferty, Borys Mankovsky, Sharon G. Adler, Linda F. Fried, Mark V. Williams, Tran Quang Khanh, Diego Aizenberg, Inés Bartolacci, Diego Besada, Julio Bittar, Mariano Chahin, Alicia Elbert, Elizabeth Gelersztein, Alberto Liberman, Laura Maffei, Federico Pérez Manghi, Hugo Sanabria, Gloria Viñes, Alfredo Wassermann, Walter P. Abhayaratna, Shamasunder Acharya, Elif I. Ekinci, Darren Lee, Peak Mann Mah, Craig Nelson, David Packham, Alexia Pape, Simon Roger, Hugo Stephenson, Michael Suranyi, Gary Wittert, Elizabeth Vale, Martin Clodi, Christoph Ebenbichler, Evelyn Fließer-Görzer, Ursula Hanusch, Michael Krebs, Karl Lhotta, Bernhard Ludvik, Gert Mayer, Peter Neudorfer ほか 1,447 名 - Annals of Internal Medicine 2023 被引用: 88

  14. Mineralocorticoid Receptor Activation and Mineralocorticoid Receptor Antagonist Treatment in Cardiac and Renal Diseases

    著者: , , - Hypertension 2014 被引用: 251

  15. Rationale and design of the Kidney Precision Medicine Project

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chirag R. Parikh, Emilio D. Poggio, Sylvia E. Rosas, Matthew R. Rosengart, Minnie Sarwal, Jennifer A. Schaub, John R. Sedor, Kumar Sharma, Becky Steck, Robert D. Toto, Olga G. Troyanskaya, Katherine R. Tuttle, Miguel A. Vazquez, Sushrut S. Waikar, Kayleen Williams, F. Perry Wilson, Kun Zhang, Ravi Iyengar, Matthias Kretzler, Jonathan Himmelfarb, Richard Knight, Stewart H. Lecker, Isaac E. Stillman, Sushrut S. Waikar, Gearoid M. McMahon, Astrid Weins, Samuel Short, Nir Hacohen, Paul Hoover, Mark P. Aulisio, Leslie Cooperman, Leal Herlitz, John O’Toole, Emilio D. Poggio, John R. Sedor, Stacey E. Jolly, Paul S. Appelbaum, Olivia Balderes, Jonathan Barasch, Andrew S. Bomback, Pietro A. Canetta, Vivette D. D’Agati, Krzysztof Kiryluk, Satoru Kudose, Karla Mehl, Jai Radhakrishnan, Chenhua Weng, Laura Barisoni, Theodore Alexandrov, Tarek Ashkar, Daria Barwinska, Pierre C. Dagher, Kenneth W. Dunn, Michael T. Eadon, Michael J. Ferkowicz, Katherine J. Kelly, Timothy A. Sutton, Seth Winfree, Steven Menez, Chirag R. Parikh, Avi Z. Rosenberg, Pam Villalobos, Rubab F. Malik, Derek M. Fine, Mohammed Atta, Jose Manuel Monroy Trujillo, Alison Slack, Sylvia E. Rosas, Mark Williams, Evren U. Azeloglu ほか 98 名 - Kidney International 2021 被引用: 190

  16. An atlas of healthy and injured cell states and niches in the human kidney

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John R. Sedor, Robert D. Toto, Chirag R. Parikh, Eric H. Kim, Evan Z. Macosko, Peter V. Kharchenko, Joseph P. Gaut, Jeffrey B. Hodgin, Michael T. Eadon, Pierre C. Dagher, Tarek M. El‐Achkar, Kun Zhang, Matthias Kretzler, Sanjay Jain - 2021 被引用: 117

  17. The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , C. David Sjöström, Anna Maria Langkilde, Hiddo J.L. Heerspink - Nephrology Dialysis Transplantation 2020 被引用: 190

  18. Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with CKD

    著者: , , , , , , , , , , , , - Journal of the American Society of Nephrology 2022 被引用: 86

  19. Prediction of Mortality and Major Adverse Kidney Events in Critically Ill Patients With Acute Kidney Injury

    著者: , , , , , , , , , - American Journal of Kidney Diseases 2022 被引用: 73

  20. Dapagliflozin and Anemia in Patients with Chronic Kidney Disease

    著者: , , , , , , , , , , , , , , - NEJM Evidence 2023 被引用: 67

  21. Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease

    著者: , , , , , , , , , , , , , , - 2021 被引用: 101

  22. Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2021 被引用: 73

  23. Resistant Hypertension: Diagnosis, Evaluation, and Treatment

    著者: , , , , , , , , , , , , , - Circulation 2008 被引用: 2,238

  24. Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis

    著者: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2002 被引用: 1,875